Xeris Pharmaceuticals | Beban Penjualan Dan Administrasi



Selling And Administration Expenses Perubahan Tanggal
Adcock Ingram Holdings ZAR 1.05B 50.17M 2024-12
Celltrion KRW 276.8B 58.09B 2025-03
Cspc Pharmaceutical CNY 1.89B 347.81M 2025-03
Dianthus Therapeutics USD 8.87M 2.04M 2025-06
Divis Laboratories Ltd 3.4B 10M 2025-06
Eli Lilly USD 2.75B 390.8M 2025-06
Kangmei Pharma CNY 259.36M 49.8M 2025-06
Knight Therapeutics CAD 25.48M 119K 2024-09
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 12.94M 5.87M 2024-12
Neuren Pharmaceuticals AUD 2.33M 47K 2024-12
Organigram Holdings CAD 25.49M 8.3M 2025-06
Pacira USD 77.19M 9.58M 2025-06
Perrigo USD 273.1M 8.1M 2025-06
Pharma Mar EUR 14.68M 1M 2025-06
Qiagen NV USD 148.74M 10.8M 2025-06
Sartorius EUR 225.2M 6.7M 2025-06
Sino Biopharmaceutical CNY 5.31B 1.54B 2024-12
Supernus Pharmaceuticals USD 62.22M 27.72M 2025-06
Tilray USD 72.38M 4.99M 2024-11
Zz Pientze Pharmaceu -171290000 342.58M 2025-06


Xeris Pharmaceuticals Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Sep 2025.